Role of ashwagandhadi capsule in high blood pressure

Clinical evaluation of the efficacy of ayurvedic compound drug (Ashwagandhadi capsule) in Hypertension with special reference to Rakta gata vata

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/046077

Enrollment

Registered

2022-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients willing to participate in study 2 Either sex of age between 18 t0 60 years 3 Stage I HTN (Systolic blood pressure 140-159mmHg and Diastolic blood pressure 90-99mmHg) 4 Isolated systolic HTN

Exclusion criteria

Exclusion criteria: 1 Patients not willing to participate in the study 2 Patients of either sex below 18 years & above 60 years will be excluded from the study 3 Patients of Stage II Hypertension (Systolic Blood Pressure >160mmHg and Diastolic Blood Pressure >100mmHg) 4 Patients suffering from serious comorbidities like renal failure, coronary artery disease, Type 2 Diabetes Mellitus, cervical spondylosis, taking medications/drugs (oral contraceptives, steroids, chronic use of NSAIDs etc.) 5 Alcoholics and/or drug abusers 6 History of hypersensitivity to the trial drug or any of its ingredients 7 Pregnant/ lactating woman

Design outcomes

Primary

Measure	Time frame
1 Systolic and Diastolic blood pressure 2 BMI 3 Lipid ProfileTimepoint: 2 months with follow up every 15 days	—

Secondary

Measure	Time frame
1 Subjective parameters assessment 2 WHO QOL BriefTimepoint: 2 months before and after trial	—

Countries

India

Contacts

Public ContactProf Rajendra Prasad

Banaras Hindu University

rajendraprasad051@gmail.com9411471910

Outcome results